التداخل بين سيفترياكسون وفيتوميناديون (فيتامين ك1)

Patients with impaired vitamin K synthesis or low vitamin K stores (e.g., chronic hepatic disease and malnutrition) may require monitoring of prothrombin time during Ceftriaxone for Injection and Dextrose Injection treatment.

Vitamin K administration (10 mg weekly) may be necessary if the prothrombin time is prolonged before or during therapy.